Zobrazeno 1 - 10
of 51
pro vyhledávání: '"O. V. Boyko"'
Autor:
A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 146-150 (2023)
A joint conclusion of the Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” on the organization of medical care, diagnosis and treatment of multiple sclerosis (MS) and other autoimmune dise
Externí odkaz:
https://doaj.org/article/22582051b1314be580478f4ed0d19f70
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 58-64 (2023)
The article reviews the evolution of interferon-β (IFN-β) in the treatment of multiple sclerosis (MS) from the first high-dose interferons to the most recent pegylated forms. The results of pivotal trials are presented and discussed. The main probl
Externí odkaz:
https://doaj.org/article/8e7a1df3d8504bacb8ba850d660a895d
Autor:
A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 1S, Pp 9-15 (2022)
Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative disease of the central nervous system. Now 2.8 million people in the world suffer from MS, since 2000 every 5 years there has been an increase in the num
Externí odkaz:
https://doaj.org/article/2e18c65337e045f1b6093e87a2b53b9f
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 1, Pp 22-25 (2022)
Objective: to evaluate the efficacy and safety of cladribine tablets as a treatment for immune reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice.Patients and methods. 34 patients with HAMS who were followed up at
Externí odkaz:
https://doaj.org/article/f27a25771699470c9d7a835029b6cbca
Autor:
A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 1S, Pp 27-30 (2021)
According to numerous studies, gut microbiota plays a significant role in multiple sclerosis (MS) development. However, data on changes in the gut microbiota in MS is often contradictory. The most common approach in gut microbiota research is the 16S
Externí odkaz:
https://doaj.org/article/11ab68bb5e3441f29b57e5396a5a62e2
Autor:
O. V. Boyko
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 0, Iss 1, Pp 135-137 (2022)
Externí odkaz:
https://doaj.org/article/1adc2f7fa88841ee9eea17ce2811f220
Autor:
O. V. Boyko, Z. Y. Hotra
Publikováno v:
Фізика і хімія твердого тіла, Vol 21, Iss 4, Pp 737-742 (2020)
The analysis of the nonlinearity of the transfer function of primary temperature transducers based on transistor structures has been performed. It’s shown that the quadratic component of the transfer function creates a significant nonlinearity erro
Externí odkaz:
https://doaj.org/article/247c38e5855e464aa94c8acbe7a1d52e
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 1S, Pp 25-28 (2020)
Cladribine tablets are a new drug for the immune reconstitution therapy of highly active multiple sclerosis (HAMS). After discussing the characteristics of action of the drug in clinical trials, the authors give their own experience of its use in the
Externí odkaz:
https://doaj.org/article/e8ce3066cfd24a7a91eb1de99f6c8079
Autor:
A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, A. V. Ivanov, A. A. Kubatiev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 3, Pp 82-86 (2020)
On March 11, 2020, the WHO announced the COVID-19 outbreak a pandemic. The disease was established to be caused by a new singlestranded RNA virus (ss-RNA, 29903 bp) that belongs to a group of coronaviruses (CoV).Objective: to assess the results of a
Externí odkaz:
https://doaj.org/article/5a0df1eb42384fb29df326e2ebdfaaad
Autor:
O. V. Boyko
Publikováno v:
Путеводитель предпринимателя, Vol 0, Iss 21, Pp 68-83 (2020)
This article contains the analysis of the reasons of insufficient development ofUnobligatory Health Insurance system in Russia and a number of offers on the mechanism of overcoming of current situation is brought. The special attention is paid to the
Externí odkaz:
https://doaj.org/article/d8f909c1dd784e29800721267bf8353f